申请人:Ferrand Sandrine
公开号:US20100041662A1
公开(公告)日:2010-02-18
A compound of Formula Ia or Ib in free or salt or solvate form, where R
1
, R
2
, R
3
, R
4
, R
5
R
20
, R
24
, R
25
, X, Y and Z have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. These compounds are also useful for treating diseases mediated by the Pi3
k
receptor, the JAK-2 receptor and the TRK receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
公式Ia或Ib的化合物以自由或盐或溶剂形式存在,其中R1、R2、R3、R4、R5R20、R24、R25、X、Y和Z的含义如规范所示,可用于治疗由ALK-5和/或ALK-4受体介导的疾病。这些化合物还可用于治疗由Pi3kreceptor、JAK-2受体和TRK受体介导的疾病。还描述了含有这些化合物的制药组合物和制备这些化合物的方法。